Novel bispecific immunoprobe for rapid and sensitive detection of prostate-specific antigen

Clinical Chemistry

Volumn 43, Issue 4, 1997, Pages 649-656

  Kreutz, Fernando T ^a   Suresh, Mavanur R ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

bispecific antibodies; hybrid hybridoma; quadroma; screening; tumor markers

Indexed keywords

BISPECIFIC ANTIBODY; MONOCLONAL ANTIBODY; PROSTATE SPECIFIC ANTIGEN;

AFFINITY CHROMATOGRAPHY; ANIMAL CELL; ANION EXCHANGE; ANTIBODY PRODUCTION; ANTIGEN DETECTION; ARTICLE; CELL LINE; ENZYME IMMUNOASSAY; HYBRIDOMA; INCUBATION TIME; MOUSE; NONHUMAN; PROSTATE CANCER;

ANIMALIA; ARMORACIA RUSTICANA;

EID: 0031003601     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/43.4.649     Document Type: Article

References (27)

1. Hostetler RM, Mandel IR, Marshburn J. Prostate cancer screening. Med Clin North Am 1996;80:83-98.
2. Mettlin C, Murphy GP, Ray P, et al. American Cancer Society-National Prostate Cancer Detection Project. Results from multiple examinations using transrectal ultrasound, digital rectal examination, and prostate specific antigen. Cancer 1993;71:891-8.
3. McCormack RT, Rittenhouse HG, Finlay JA, et al. Molecular forms of prostate-specific antigen and the human kallikrein gene family: a new era. Urology 1995;45:729-44.
4. Diamandis EP, Yu H. New biological functions of prostate-specific antigen? J Clin Endocrinol Metab 1995;80:1515-7.
5. Stenman UH, Hakama M, Knekt P, Aromaa A, Teppo L, Leinonen J. Serum concentrations of prostate specific antigen and its complex with alpha 1-antichymotrypsin before diagnosis of prostate cancer. Lancet 1994;344:1594-8.
6. Christensson A, Laurell CB, Lilja H. Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors. Eur J Biochem 1990;194:755-63.
7. 1-antichymotrypsin. Clin Chem 1993;39:2098-103.
8. Luderer AA, Chen YT, Soriano TF, et al. Measurement of the proportion of free to total prostate-specific antigen improves diagnostic performance of prostate-specific antigen in the diagnostic gray zone of total prostate-specific antigen. Urology 1995;46:187-94.
9. Oesterling JE, Moyad MA, Wright GL Jr, Beck GR. An analytical comparison of the three most commonly used prostate-specific antigen assays: Tandem-R, Tandem-E, and IMx. Urology 1995;46:524-32.
10. Armbruster DA. Prostate-specific antigen: biochemistry, analytical methods, and clinical application [Review]. Clin Chem 1993;39:181-95.
11. Cattini R, Cooksey M, Robinson D, Brett G, Bacarese-Hamilton T, Jolley N. Measurement of alpha-fetoprotein, carcinoembryonic antigen and prostate-specific antigen in serum and heparinised plasma by enzyme immunoassay on the fully automated Serono SR1 analyzer. Eur J Clin Chem Clin Biochem 1993;31:517-24.
12. Khosravi MJ, Papanastasiou-Diamandi A, Mistry J. An ultrasensitive immunoassay for prostate-specific antigen based on conventional colorimetric detection. Clin Biochem 1995;28:407-14.
13. Klee GG, Preissner CM, Oesterling JE. Development of a highly sensitive immunochemiluminometric assay for prostate-specific antigen. Urology 1994;44:76-82.
14. Vihko P, Kurkela R, Ramberg J, Pelkonen I, Vihko R. Time-resolved immunofluorometric assay of human prostate-specific antigen. Clin Chem 1990;36:92-5.
15. Yu H, Diamandis EP. Ultrasensitive time-resolved immunofluorometric assay of prostate-specific antigen in serum and preliminary clinical studies. Clin Chem 1993;39:2108-14.
16. Milstein C, Cuello AC. Hybrid hybridomas and their use in immunohistochemistry. Nature 1983;305:537-40.
17. Suresh MR, Cuello AC, Milstein C. Bispecific monoclonal antibodies from hybrid hybridomas. Methods Enzymol 1986;121:210-28.
18. Kreutz FT, Suresh MR. Bispecific monoclonal anti-CA125 × anti-peroxidase antibodies in the measurement of the ovarian carcinoma antigen. J Tumor Marker Oncol 1995;10:45-53.
19. Nolan O, O'Kennedy R. Bifunctional antibodies and their potential clinical applications. Int J Clin Lab Res 1992;22:21-7.
20. Jette DC, Kreutz FT, Malcolm BA, Wishart D, Noujaim AA, Suresh MR. Epitope mapping of prostate-specific antigen with monoclonal antibodies. Clin Chem 1996;42:1961-9.
21. Harlow E, Lane D. Immunoaffinity purification. In: Harlow E, Lane D, eds. Antibodies: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1988:511-51.
22. Kranz DM, Gruber M, Wilson ER. Properties of bispecific single chain antibodies expressed in Escherichia coli. J Hematother 1995;4:403-8.
23. Carter P, Ridgway J, Zhu Z. Toward the production of bispecific antibody fragments for clinical applications. J Hematother 1995;4:463-70.
24. Cook AG, Wood PJ. Chemical synthesis of bispecific monoclonal antibodies: potential advantages in immunoassay systems. J Immunol Methods 1994;171:227-37.
25. Fanger MW, Morganelli PM, Guyre PM. Bispecific antibodies. Crit Rev Immunol 1992;12:101-24.
26. Ferguson RA, Yu H, Kalyvas M, Zammit S, Diamandis EP. Ultrasensitive detection of prostate-specific antigen by a time-resolved immunofluorometric assay and the Immulite® immunochemiluminescent third-generation assay: potential application in prostate and breast cancers. Clin Chem 1996;42:675-84.
27. Suresh MR, Cuello AC, Milstein C. Advantages of bispecific hybridomas in one-step immunocytochemistry and immunoassays. Proc Natl Acad Sci U S A 1986;83:7989-93.